Volunteers get 2nd shot of Nano Covax vaccine in second trial phase
The Military Medical University under the Ministry of National Defence on March 25 began giving the second shots of the Nano Covax COVID-19 vaccine in the second trial phase to 26 volunteers who receive the first jabs between February 26 and March 10.
A volunteer gets her 2nd shot of Nano Covax vaccine in the second trial phase (Photo: VNA)
Hanoi (VNA)- The Military Medical University under the Ministry of National Defence on March25 began giving the second shots of the Nano Covax COVID-19 vaccine in the second trial phase to 26 volunteers whoreceive the first jabs between February 26 and March 10.
Nano Covax developed by the NanogenPharmaceutical Biotechnology Company is Vietnam’s first candidate vaccine to reachthe human trial stage.
According to Associate Prof. Dr. Chu Van Men, Director of the Military Medical University’sCentre for Clinical Trials and Bioequivalence, after receiving the first shots,volunteers exhibited symptoms such as pain at the injection point, a light fever, muscle aches, joint pain, and fatigue, but did notrequire medical intervention.
The health of the 560 volunteers remains stable, he said, adding that NanoCovax is safe and the volunteers are ready for their second shots.
The second trial is being organised simultaneously at the Military Medical Universityand the Pasteur Institute in Ho Chi Minh City, with volunteers including thosewith mild background ailments such as hypertension, diabetes, and cardiovascularissues.
As planned, the MilitaryMedical University will submit the preliminary test results to the Ministry of Healthand the National Council for Ethics in Biomedical Research in May forreview and evaluation, before conducting the third phase of trials.
Previously, at ameeting of standing members of the National Steering Committee for COVID-19 Preventionand Control, a representative from the Ministry of Health said that the third phaseof trials will take place from May to September, with the vaccine then registeredfor circulation in September, three months earlier than scheduled.
Vietnam expects to have its locally-produced vaccine available by the end of thethird quarter./.
The second phase of the human trials of Nano Covax, a homegrown COVID-19 vaccine, will begin on February 26, following the first phase that has been proven safe.
Nearly 300 volunteers in the Mekong Delta province of Long An are set to receive injections of Nano Covax in the second-stage human clinical trials of the COVID-19 vaccine candidate from Vietnam.
A total of 367 volunteers, including 30 aged over 60, have been injected with Nano Covax, Vietnam’s first homegrown COVID-19 vaccine candidate, in the second phase of its human trials, according to the Military Medical University.
The Hanoi-based Vietnam Military Medical University and the Pasteur Institute in Ho Chi Minh City have completed the administration of the first doses of Nano Covax in the second-stage human trials of this homegrown COVID-19 candidate vaccine.
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Despite the ongoing global circulation and unpredictable developments of SARS-CoV-2, the World Health Organisation (WHO) hasn’t issued new warnings about COVID-19, said the Ministry of Health.
A volunteer gets her 2nd shot of Nano Covax vaccine in the second trial phase (Photo: VNA) 
